Kristi Berzansky
Medical · Broad Top, PANPI 1659665008
Payments from drug & device makers
Across 137 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$455
- Novo Nordisk$247
- Exact Sciences$245
- Lilly USA, LLC$180
- Amgen$106
- AstraZeneca$93
- plus $740 from 17 others
What the payments were for
- Food & beverage$2,065100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 43 | $455 |
| Novo Nordisk | 14 | $247 |
| Exact Sciences | 12 | $245 |
| Lilly USA, LLC | 12 | $180 |
| Amgen | 6 | $106 |
| AstraZeneca | 6 | $93 |
| Pfizer | 6 | $89 |
| Bayer | 5 | $84 |
| Sanofi-aventis U.S. LLC | 5 | $79 |
| Merck | 5 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $56 |
| Boehringer Ingelheim | 4 | $55 |
| Nevro Corp. | 1 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| Abbott | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $33 |
| Corcept Therapeutics | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Seqirus USA Inc | 1 | $26 |
| AbbVie | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
How this compares
$2,065 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $78,933 |
| TrulicityDulaglutide | 68 | $64,704 |
| EliquisApixaban | 82 | $50,013 |
| JardianceEmpagliflozin | 46 | $37,218 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $32,895 |
| JanuviaSitagliptin Phosphate | 21 | $15,658 |
| TradjentaLinagliptin | 18 | $12,817 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $9,249 |
| Tresiba Flextouch U-200Insulin Degludec | 15 | $9,204 |
| Breo ElliptaFluticasone/Vilanterol | 17 | $9,153 |
| Spiriva RespimatTiotropium Bromide | 12 | $7,802 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $5,748 |
| Metoprolol Succinate | 121 | $2,465 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 81 | $2,290 |
| Atorvastatin Calcium | 170 | $1,811 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $247 | $78,93369 claims |
| Lilly USA, LLCTrulicity | $180 | $64,70468 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $55 | $57,83776 claims |
| PfizerEliquis | $89 | $50,01382 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $455 | $42,04866 claims |
| MerckJanuvia | $74 | $15,65821 claims |
| Sanofi-aventis U.S. LLCLantus | $79 | $76512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Broad Top
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.